At the start of the Nov 6 Friday evening session, Shanghai Gold Exchange Gold T+D fell 0.1% to 871.2 yuan/gram; Silver T+D rose 0.07% to 12,425 yuan/kg.

JD Health (06618.HK) CEO Cao Dong said at the China International Import Expo the company will sign agreements with more than 20 global pharmaceutical and health brands, including Pfizer, Merck, Novo Nordisk, Takeda, Boehringer Ingelheim, Novartis and Leo Pharma. Several partners have worked with JD Health for over a decade; the new deals expand cooperation beyond product launches and exclusive distribution to patient management and AI-driven innovations. JD Health says it now has deep partnerships with 50 of the world’s top multinationals, and has completed more than 100 online first launches of new drugs through Q3 2026, exceeding last year’s total.

AMP chief economist and head of investment strategy Sean Oliver said investors are still gauging the market impact of a Democratic win in the midterm elections and outcomes remain unclear. Recent volatility reflects mounting concern that tech and AI-related positions are overvalued, leaving them more vulnerable to shocks. Those valuation pressures have been building and the midterms may merely have been the trigger for a pullback. Oliver cautioned it is too early to call a market bottom; if the economic outlook is unchanged, the fall is likelier to be a correction than the start of a bear market.